{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3614, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed footnotes explaining adjustments and share repurchase program details.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/26", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/27", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed footnotes regarding fund exclusions, IRR calculation methodology, and vintage year applicability.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/28", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide presents a breakdown of assets by segment (Asset Management and Retirement Services) with specific line items for cash, investments, and other assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/29", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "Financial data table showing liabilities and equity components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/30", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed footnotes explaining specific adjustments like equity-based profit sharing and non-operating changes in insurance liabilities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/31", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes explaining specific adjustments like equity-based compensation and merger-related costs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/32", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes regarding adjustments for consolidated funds, VIEs, and profit sharing arrangements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/33", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table provides a detailed breakdown of adjustments including investment gains/losses, non-operating changes, and stock compensation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/34", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide contains two distinct sub-tables for different asset categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/35", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard financial disclosure slide defining non-GAAP metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/36", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_disclosure", "function": "other", "notes": "This is a standard financial definitions page found in investor presentations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/37", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_disclosure", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/38", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_disclosure", "function": "appendix", "notes": "This is a standard disclosure/definitions slide common in financial investor presentations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/39", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "appendix_disclosure", "function": "other", "notes": "This is a standard appendix slide providing technical definitions and endnote clarifications for a financial presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/40", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e5ac-72df-97de-2e6f08a6df4d", "docSlug": "5afc2e981a1abd51eab65e621d626b8b", "documentTitle": "Apollo Global Management | Results Presentation Deck | 41 slides", "authorId": "apollo-global-management", "authorName": "Apollo Global Management", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e5ac-72df-97de-2e6f08a6df4d/41", "deckHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d", "deckAnchorHref": "/decks/019de075-e5ac-72df-97de-2e6f08a6df4d#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 41, "from": 21, "beatId": "0f38e0de-86dd-4439-ad52-0c5869cfb769", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The deck concludes with reconciliations, disclosures, and forward-looking statements to guide future actions", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/WiVnjZybTfLiP6Nkf3n8zOG_c-xKBEHjb4MvVnWkx_o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MTIyZTNjYTNlZjY1ODE5MGU0ODUxZmY3MGUxOWY2MS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/1", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/B1yo6nF4kFoyExoL_MjPmRIJTKYqtmkQwAuxV3ho8jo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MTIyZTNjYTNlZjY1ODE5MGU0ODUxZmY3MGUxOWY2MS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/cocuZdv_9gHhhIL5y05IGvhg84nPNhapojuZ40R-5g8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MTIyZTNjYTNlZjY1ODE5MGU0ODUxZmY3MGUxOWY2MS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Fyd_cLyMaWAdaLdfjDs5tGMKBqzUT6yCh3e1aOP5VAw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MTIyZTNjYTNlZjY1ODE5MGU0ODUxZmY3MGUxOWY2MS9wMDAxLnBuZw" }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/2", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "solution", "function": "present_solution", "notes": "The slide outlines the core therapeutic strategy of Arbutus Biopharma.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/3", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-3", "loopMatches": [ { "to": 5, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "740fe1b5-bbc6-449b-92b2-3662c17d1011", "evidence": "Our Strategy for Value Creation, Investment Highlights, Pipeline", "position": 1, "objective": "explain the company's strategy and value creation", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "e5f6dd36-1068-4403-8d6c-aaa6a690260f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Our Strategy for Value Creation, Investment Highlights, Pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a column-based layout to present key value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/4", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-4", "loopMatches": [ { "to": 5, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "740fe1b5-bbc6-449b-92b2-3662c17d1011", "evidence": "Our Strategy for Value Creation, Investment Highlights, Pipeline", "position": 1, "objective": "explain the company's strategy and value creation", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "e5f6dd36-1068-4403-8d6c-aaa6a690260f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Our Strategy for Value Creation, Investment Highlights, Pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/5", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-5", "loopMatches": [ { "to": 5, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "740fe1b5-bbc6-449b-92b2-3662c17d1011", "evidence": "Our Strategy for Value Creation, Investment Highlights, Pipeline", "position": 1, "objective": "explain the company's strategy and value creation", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "e5f6dd36-1068-4403-8d6c-aaa6a690260f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Our Strategy for Value Creation, Investment Highlights, Pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "context", "function": "establish_context", "notes": "The slide uses a four-column layout to structure the disease overview.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/6", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "1fd38620-0355-494b-8110-485e59feaa7e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "HBV Overview and HBV Presents a Significant Unmet Medical Need", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 6, "from": 6, "beatId": "ffc17fa1-4375-4add-a7ea-7b04e5fc7a17", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "HBV Overview", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a geographic map and a nested circle diagram to illustrate the treatment gap.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/7", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-7", "loopMatches": [ { "to": 8, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "76882cac-b39a-4c73-bd50-681a12eb8cde", "evidence": "HBV Presents a Significant Unmet Medical Need, Therapeutic success will require a combination of agents", "position": 0, "objective": "highlight the need for effective HBV treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "1fd38620-0355-494b-8110-485e59feaa7e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "HBV Overview and HBV Presents a Significant Unmet Medical Need", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/8", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-8", "loopMatches": [ { "to": 8, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "76882cac-b39a-4c73-bd50-681a12eb8cde", "evidence": "HBV Presents a Significant Unmet Medical Need, Therapeutic success will require a combination of agents", "position": 0, "objective": "highlight the need for effective HBV treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/9", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights the mechanism of action and key therapeutic benefits of the drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/10", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "d2e1c560-c296-4472-968d-b63e27e07b30", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Imdusiran RNAi Therapeutic, Robust HBsAg declines, Imdusiran demonstrates robust and sustained HBsAg declines", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "The slide outlines the study design for cohorts E through K in Part 3 of the trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/11", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "d2e1c560-c296-4472-968d-b63e27e07b30", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Imdusiran RNAi Therapeutic, Robust HBsAg declines, Imdusiran demonstrates robust and sustained HBsAg declines", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "analyze_data", "notes": "Data shows consistent efficacy across different patient subgroups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/12", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "d2e1c560-c296-4472-968d-b63e27e07b30", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Imdusiran RNAi Therapeutic, Robust HBsAg declines, Imdusiran demonstrates robust and sustained HBsAg declines", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide displays longitudinal clinical trial data for a drug candidate (Imdusiran) across various dosing regimens (Cohorts E, F, I, J, G, K).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/13", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "d2e1c560-c296-4472-968d-b63e27e07b30", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Imdusiran RNAi Therapeutic, Robust HBsAg declines, Imdusiran demonstrates robust and sustained HBsAg declines", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Clinical trial data showing individual patient responses over time, including two cases of NA retreatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/14", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "d2e1c560-c296-4472-968d-b63e27e07b30", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Imdusiran RNAi Therapeutic, Robust HBsAg declines, Imdusiran demonstrates robust and sustained HBsAg declines", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/15", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 10, "beatId": "d2e1c560-c296-4472-968d-b63e27e07b30", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "Imdusiran RNAi Therapeutic, Robust HBsAg declines, Imdusiran demonstrates robust and sustained HBsAg declines", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "summarize", "notes": "The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and stability of laboratory markers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/16", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/17", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial randomization and treatment arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/18", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "Shows two parallel trial arms with timelines and patient counts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/19", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "other", "function": "other", "notes": "The slide details the financial terms of the deal and the scope of the partnership.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/20", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/21", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/22", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a three-column layout to explain the scientific basis and product advantages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/23", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide includes a financial summary at the top and a list of clinical trial milestones with completion checkmarks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/24", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 24, "beatId": "96545f47-46d2-4638-8966-b5a0c7c3cf4d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "The Ask", "beatSlug": "sequoia-pitch-the-ask", "evidence": "2023 Key Milestones, Thank You", "position": 5, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e64c-773b-a5bd-08e51f7033a7", "docSlug": "8122e3ca3ef658190e4851ff70e19f61", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 25 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e64c-773b-a5bd-08e51f7033a7/25", "deckHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7", "deckAnchorHref": "/decks/019de075-e64c-773b-a5bd-08e51f7033a7#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 25, "from": 24, "beatId": "96545f47-46d2-4638-8966-b5a0c7c3cf4d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "The Ask", "beatSlug": "sequoia-pitch-the-ask", "evidence": "2023 Key Milestones, Thank You", "position": 5, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/ypml7Wn_Sf47OGPKcVqaKCcXYqKIQTugVO4INtOP1Hw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNmVjZWJiMTQzZWQ0NGJlMjRlNzJiNzc3ZmZmOGNiMy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/1", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/Sv7sAnDnW350fNNJzV1LGCCnI81Qzoox192OIPwcDdo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNmVjZWJiMTQzZWQ0NGJlMjRlNzJiNzc3ZmZmOGNiMy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/5Hen1IS5qwnIUxZ1sbVNRTktsmfA9fGixJyOw-F7uek/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNmVjZWJiMTQzZWQ0NGJlMjRlNzJiNzc3ZmZmOGNiMy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/moMVdDoRL40PIW-kO_foZ6e8ko8wBl2SXlxYAGTbThM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNmVjZWJiMTQzZWQ0NGJlMjRlNzJiNzc3ZmZmOGNiMy9wMDAxLnBuZw" }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/2", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a circular process flow diagram to illustrate the company's growth strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/3", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "03dc2166-e1da-46b9-bed1-765f6d705cf1", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "The key takeaways slides provide an overview of the company's current state and goals.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/4", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "03dc2166-e1da-46b9-bed1-765f6d705cf1", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "The key takeaways slides provide an overview of the company's current state and goals.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "other", "function": "present_framework", "notes": "The slide uses a timeline-based clinical trial design framework.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/5", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a randomized clinical trial structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/6", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a list format to communicate a roadmap of clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/7", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-7", "loopMatches": [ { "to": 9, "from": 7, "name": "Maturity Curve", "slug": "36-maturity-curve", "bestFor": "Digital transformation, capability building, benchmarking", "matchId": "715e4145-954a-4e79-8010-a8f97a84e746", "evidence": "The roadmap slides outline the company's plans for expansion and growth, which can be related to a maturity curve.", "position": 0, "objective": "To show the company's growth and expansion plans", "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap", "confidence": 0.6, "description": "Show where you are on a progression and what it takes to reach the next level" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "19d943f9-ff17-4d55-aa5e-7961c606f396", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Roadmap", "beatSlug": null, "evidence": "The roadmap slides outline the company's plans for expansion and growth.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/8", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-8", "loopMatches": [ { "to": 9, "from": 7, "name": "Maturity Curve", "slug": "36-maturity-curve", "bestFor": "Digital transformation, capability building, benchmarking", "matchId": "715e4145-954a-4e79-8010-a8f97a84e746", "evidence": "The roadmap slides outline the company's plans for expansion and growth, which can be related to a maturity curve.", "position": 0, "objective": "To show the company's growth and expansion plans", "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap", "confidence": 0.6, "description": "Show where you are on a progression and what it takes to reach the next level" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "19d943f9-ff17-4d55-aa5e-7961c606f396", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Roadmap", "beatSlug": null, "evidence": "The roadmap slides outline the company's plans for expansion and growth.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 8, "from": 8, "beatId": "16aa99f9-3038-4e15-b9bb-5e8d059b9e43", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Financial Summary", "beatSlug": null, "evidence": "The financial summary slide provides an overview of the company's current financial situation.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a 2D matrix-like structure to show expansion vectors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/9", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-9", "loopMatches": [ { "to": 9, "from": 7, "name": "Maturity Curve", "slug": "36-maturity-curve", "bestFor": "Digital transformation, capability building, benchmarking", "matchId": "715e4145-954a-4e79-8010-a8f97a84e746", "evidence": "The roadmap slides outline the company's plans for expansion and growth, which can be related to a maturity curve.", "position": 0, "objective": "To show the company's growth and expansion plans", "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap", "confidence": 0.6, "description": "Show where you are on a progression and what it takes to reach the next level" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "19d943f9-ff17-4d55-aa5e-7961c606f396", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Roadmap", "beatSlug": null, "evidence": "The roadmap slides outline the company's plans for expansion and growth.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a central circular image overlaying a four-quadrant layout of strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/10", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-10", "loopMatches": [ { "to": 10, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "484a0547-0710-489d-954a-49b891ff735a", "evidence": "The key takeaways slide provides an overview of the company's strategies for optimizing core launch strategies, which can be related to quick wins and big bets.", "position": 1, "objective": "To highlight the company's strategies for optimizing core launch strategies", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 10, "from": 10, "beatId": "f8ad4558-1503-425b-bc68-40634c5b2fe8", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "The key takeaways slide provides an overview of the company's strategies for optimizing core launch strategies.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a chronological progression (Today vs Future) to outline product development milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/11", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "geographic_map", "function": "establish_context", "notes": "The map uses teal dots for VYVGART and a purple dot for VYVGART Hytrulo, though the legend is implicit in the side tables.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/12", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide combines corporate messaging with a personal patient story to humanize the clinical data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/13", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e6e6-7212-9fa1-8acb312e82f0", "docSlug": "a6ecebb143ed44be24e72b777fff8cb3", "documentTitle": "argenx SE | Results Presentation Deck | 14 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a hub-and-spoke visual metaphor to represent corporate values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e6e6-7212-9fa1-8acb312e82f0/14", "deckHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0", "deckAnchorHref": "/decks/019de075-e6e6-7212-9fa1-8acb312e82f0#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e7b0-744f-b0ad-1fad13504931", "docSlug": "7ec46e94e77a6fe42ae3660a879353f3", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 18 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/M5YmuqKaE3DFdiY2lTJysElRawab9oO7Y5hIPVEJ7xs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZWM0NmU5NGU3N2E2ZmU0MmFlMzY2MGE4NzkzNTNmMy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e7b0-744f-b0ad-1fad13504931/1", "deckHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931", "deckAnchorHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "fd62a3e2-0a72-4768-9012-d6cae37f401d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and executive summary grab the audience's attention", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/TENjeS4TDuMpoco5COFiKywL5qXbpbvaLJkBaYd2tsI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZWM0NmU5NGU3N2E2ZmU0MmFlMzY2MGE4NzkzNTNmMy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/GwA985P5TDRahC7U87viZX88Sf-Z3dku-81KsBtrLfI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZWM0NmU5NGU3N2E2ZmU0MmFlMzY2MGE4NzkzNTNmMy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/-Dz6oZg3G11liPSzwt8LwQ9mM6wdEpm9vSHNt04srDA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZWM0NmU5NGU3N2E2ZmU0MmFlMzY2MGE4NzkzNTNmMy9wMDAxLnBuZw" }, { "docId": "019de075-e7b0-744f-b0ad-1fad13504931", "docSlug": "7ec46e94e77a6fe42ae3660a879353f3", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 18 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "executive_summary", "function": "summarize", "notes": "Includes financial metrics (revenue, profit, EBITDA, liquidity, debt) and operational updates (product launches, financing, partnerships).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e7b0-744f-b0ad-1fad13504931/2", "deckHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931", "deckAnchorHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "fd62a3e2-0a72-4768-9012-d6cae37f401d", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and executive summary grab the audience's attention", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e7b0-744f-b0ad-1fad13504931", "docSlug": "7ec46e94e77a6fe42ae3660a879353f3", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 18 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a decorative abstract image on the right side.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e7b0-744f-b0ad-1fad13504931/3", "deckHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931", "deckAnchorHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "abe1ecf0-03b6-478b-abb1-7884f487430e", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The financial results and wholesales data highlight the company's current situation", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e7b0-744f-b0ad-1fad13504931", "docSlug": "7ec46e94e77a6fe42ae3660a879353f3", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 18 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a donut chart for volume distribution and a stacked bar chart for ASP comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e7b0-744f-b0ad-1fad13504931/4", "deckHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931", "deckAnchorHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "abe1ecf0-03b6-478b-abb1-7884f487430e", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The financial results and wholesales data highlight the company's current situation", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e7b0-744f-b0ad-1fad13504931", "docSlug": "7ec46e94e77a6fe42ae3660a879353f3", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 18 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "geographic_map", "function": "analyze_data", "notes": "The slide uses a map-based visualization to show regional performance, with callout bubbles for percentage change and bar charts for absolute volume.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e7b0-744f-b0ad-1fad13504931/5", "deckHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931", "deckAnchorHref": "/decks/019de075-e7b0-744f-b0ad-1fad13504931#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "abe1ecf0-03b6-478b-abb1-7884f487430e", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The financial results and wholesales data highlight the company's current situation", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }